Abstract
Few drugs have gained comparable importance, in almost any field of medical therapy, to corticosteroids. For the ophthalmologist, corticosteroids remain one of the basic therapeutics in a broad spectrum of inflammatory conditions. This review is intended to summarize some relevant aspects on the use of corticosteroids, their main indications, as well as their limitations in ophthalmology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Armaly MF (1966) The heritable nature of dexamethasone-induced ocular hypertension. Arch Ophthalmol 75: 32 - 35
Barnes PJ, Adcock I (1993) Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 172: 436 - 441
Bettmann JW, Fund WE, Webster RG, Noyes PP, Vincent NJ (1967) Cataracto- genic effect of corticosteroids on animals. Am J Ophthalmol 63: 841 - 844
Black RL, Oglesby RB, von Sallman L, et al (1960) Posterior subcapsular cataracts induced by corticoids in patients with rheumatoid arthritis. JAMA 174: 166 - 171
Blake EM, Fasanella RM, Wong AS (1950) The effect of ACTH in glaucoma. Am J Ophthalmol 33: 1231 - 1235
Bodor B (1994) Designing softer ophthalmic drugs by soft drug approaches. J Ocul Pharmacol Ther 10: 3 - 15
Carnahan MC, Goldstein DA (2000) Ocular complications of topical, peri-ocu-lar and systemic corticosteroids. Curr Opin Ophthalmol 11: 478 - 483
Chylack LT (1997) Cataracts and inhaled corticosteroids. N Engl J Med 337: 46 - 48
Derby L, Maier WC (2000) Risk of cataract among users of intranasal corticosteroids. J Allergy Clin Immunol 105: 912 - 916
Dick AD (1999) Immune regulation of uveoretinal inflammation. In: Pleyer U, Zierhut M, Behrens-Baumann W (eds) Immuno-ophthalmology. S. Karger AG, Basel, pp 187 - 203
Elkinton JR, Hunt AD Jr, Godfrey L, McCory WW, Stokes J Jr (1949) Effects of pituitary adrenocorticotropic hormone ( ACTH) therapy. JAMA 141: 1273-1279
Foreman AR, Loreto JA, Tina LV (1977) Reversibility of corticosteroid-associated cataracts in children with the nephrotic syndrome. Am J Ophthalmol 84: 75 - 78
Friedberg M, Pleyer U, Mondino BJ (1991) Device drug delivery: collagen shields, iontophoresis, pumps. Ophthalmology 98: 725 - 732
Garbe E, Suissa S, LeLorier J (1998) Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA 280: 539 - 543
Hanania NA, Chapman KR, Kesten S (1995) Adverse effects of inhaled corticosteroids. Am J Med 98: 196 - 208
Howes JF (2000) Loteprednol etabonate: a review of ophthalmic clinical studies. Pharmazie 55: 178 - 183
Hull DS, Hine JE, Edelhauser HF, Hyndius RA (1974) Permeability of the isolated rabbit cornea to corticosteroids. Invest Ophthalmol Vis Sci 13: 457 - 459
Jaffe GJ, Yang CH, Guo H, Denny JP, Lima C, Ashton P (2000) Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device. Inv Ophthalmol Vis Sci 41: 3569 - 3575
Johnson D, Gottanka J, Flugel C, Hoffmann F, Futa R, Lutjen Drecoll E (1997) Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol 115: 375 - 383
Kaplan HL (1984) Intermediate uveitis (pars planitis, chronic cyclitis): a four-step approach to treatment. In: Saari KM (ed) Uveitis update. Exerpta Medica 1984, Amsterdam, pp 169 - 172
Leibowitz HM, Bartlett JD, Rich R, McQuirter H, Stewart R, Assil K (1996) Intraocular pressure-raising potential of 1% rimexolone in patients responding to corticosteroids. Arch Ophthalmol 114: 933 - 937
Leibowitz HM, Kupferman A (1976) Kinetics of topically administered prednisolone acetate. Arch Ophthalmol 94: 1387 - 1389
Mann WA, Markson DE (1950) A case of recurrent iritis and episcleritis on a rheumatic basis treated with ACTH. Am J Ophthalmol 33: 459 - 461
McLean JM (1950) Clinical and experimental observation on the use of ACTH and cortisone in ocular inflammatory disease. Trans Am Ophthalmol Soc 48: 259
Milani JK, Verbukh I, Pleyer U, Sumner H, Adamu SA, Halabi Hi, Chou HI, Lee DA, Mondino BJ (1993) Collagen shields impregnated with gentamycin-dexamethasone combination as a potential drug delivery device. Am J Ophthalmol 116: 622 - 627
Mitchell P, Cumming RG, Mackey DA (1999) Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology 106: 2301 - 2306
Novack GD, Howes J, Crockett RS, Sherwood MB (1998) Change in intraocular pressure during long-term use of loteprednol etabonate. J Glaucoma 7: 266 - 269
Olson JA, Steffensen EH, Margulis RR, Smith RW, Whitney EL (1950) Effect of ACTH on certain inflammatory diseases of the eye. JAMA 142: 1276 - 1278
Ozerdem U, Levi L, Cheng L, Song MK, Scher C, Freeman WR (2000) Systemic toxicity of topical and periocular corticosteroid therapy in an 11-yearold male with posterior uveitis. Am J Ophthalmol 130: 240 - 241
Pleyer U, Lutz S, Jusko WJ, Nguyen K, Narawane M, Rückert D, Mondino BJ, Lee VHL (1993) Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye. Invest Ophthalmol Vis Sci 34: 2737 - 2742
Pleyer U, Elkins B, Rückert D, Lutz S, Grammer J, Chou J, Schmidt KH, Mondino BJ (1994) Ocular absorption of cyclosporine A from liposomes incorporated into collagen shields. Curr Eye Res 13: 177 - 181
Pleyer U, Rieck P, Ritter T, Hartmann C (1998) Immunreaktion nach perforierender Keratoplastik. Ophthalmologe 95: 444 - 459
Pleyer U, Liekfeld A, Baatz H, Hartmann C (1999) Pharmakologische Modulation immunmediierter Erkrankungen des Auges. Klin Monatsbl Augenheilkd 214: 160 - 170
Polansky JR, Fauss DJ, Zimmerman CC (2000) Regulation of TIGR/MYOC gene expression in human trabecular meshwork cells. Eye 14: 503 - 514
Rauz S, Walker EA, Shackleton CH, Hewison M, Murray PI, Stewart PM (2001) Expression and putative role of 11 beta-hydroxysteroid dehydrogenase isozymes within the human eye. Invest Ophthalmol Vis Sci 42: 2037 - 2042
Southern AL, Altman K, Vittek J, Boniuk V, Gordon GG (1976) Steroid metabolism in ocular tissues of the rabbit. Invest Ophthalmol Vis Sci 15: 222 - 228
Southern AL, Gordon GG, Yeh HS, Dunn MW, Weinstein BI (1977) Receptors for glucocorticoids in the lens epithelium of the calf. Science 200: 1177 - 1178
Stern JJ (1953) Acute glaucoma during cortisone therapy. Am J Ophthalmol 36: 389 - 390
Stone EM, Tingert JH, Wallace LM, Nguyen TD, Polansky JR, Sheffield VC (1997) Identification of a gene that causes primary open-angle glaucoma. Science 275: 668 - 670
Sugar J, Burde RM, Sugar A, Waltman SR, Kripalani KJ, Weliky I, Becker B (1972) Tetrahydrotriamcinolone and triamcinolone I. Ocular penetration. Invest Ophthalmol Vis Sci 11: 890-893
Tamada Y, Miyashita H, Ono S (1980) Studies on phospholipid metabolism of rabbit lens with special references to long-term topical administration of steroid. Jap J Ophthalmol 24: 289 - 296
Urban RC Jr, Cotlier E (1986) Corticosteroid-induced cataracts. Sury Ophthalmol 31: 102 - 110
Watson D, Noble MJ, Dutton GN, Midgley JM, Healey TM (1988) Penetration of topically applied dexamethasone alcohol into human aqueous humor. Arch Ophthalmol 106: 686 - 687
Weiner A, BenEzra D (1991) Clinical patterns and associated conditions in chronic uveitis. Am J Ophthalmol 112: 151 - 158
Woods AC (1950) Clinical and experimental observations on the use of ACTH and cortisone in ocular inflammatory disease. Am J Ophthalmol 33: 1325 - 1349
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Pleyer, U., Sherif, Z. (2002). Corticosteroids in Ophthalmology. In: Cato, A.C.B., Schäcke, H., Asadullah, K. (eds) Recent Advances in Glucocorticoid Receptor Action. Ernst Schering Research Foundation Workshop, vol 40. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-04660-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-662-04660-9_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-04662-3
Online ISBN: 978-3-662-04660-9
eBook Packages: Springer Book Archive